Dear individual shareholder,
Welcome to this section especially dedicated to you. Throughout these pages we provide our individual shareholders and all those who are interested in our shares with information on the Group’s commitment towards its shareholders.
If you want to learn more about Sanofi, contact the Sanofi Individual Shareholder Relations team in:
France at +33 800 075 876 or
the United States at +1 888 516 3002.
Letter to Shareholders - June 2014
This new issue of the Letter focuses on Q1 2014 results, our dengue vaccine candidate, Genzyme's options for multiple sclerosis patients and the AGM 2014.
June 10, 2014
Individual shareholder meeting in Lyon
Shareholder Handbook - 2014 edition
This handbook presents key figures for 2013 and provides information about managing Sanofi shares.
Annual Review 2013
The Annual Review presents the Group's strategy and operations in 2013.
CSR Report 2013
The CSR (Corporate Social Responsibility) Report gives an update on our social, community, ethical and environmental responsibilities.
April 29, 2014
First-Quarter 2014 Results
First quarter results for 2014 were reviewed by management during a conference call with the financial community.
The Annual General Meeting approved a dividend of €2.80 per share
• May 12, 2014: Ex-date
• May 14, 2014: Record date
• May 15, 2014: Payment date
IR mobile application
SANOFI IR is available on iPhone, iPad and Android!
Annual General Meeting 2014
The General Meeting was held on May 5, 2014 in Paris.